Skip to product information
1 of 1

Rafutrombopag [CAS 2600513-51-5]

Rafutrombopag [CAS 2600513-51-5]

Size

SKU:QM-0066293

Price on request
Quantity

Request quote or documents

View full details
  • Description

    Rafutrombopag (Hetrombopag) is an orally active nonpeptide thrombopoietin receptor (TPOR/MPL) agonist. Rafutrombopag can chelate iron and alleviate iron overload while promoting haematopoiesis. Rafutrombopag specifically stimulates proliferation and differentiation of human TPOR‐expressing cells, including 32D‐ MPL and human hematopoietic stem cells through stimulation of STAT, PI3K and ERK signalling pathways. Rafutrombopag effectively up-regulates G1-phase-related proteins, including p-RB, Cyclin D1 and CDK4/6, normalizes progression of the cell cycle, and prevents apoptosis by modulating BCL-XL/BAK expression in 32D-MPL cells. Rafutrombopag protects cardiomyocyte survival from oxidative stress damage as an enhancer of stem cells. Rafutrombopag can be used for the study of immune thrombocytopenia and oxidative stress-related cardiovascular disease[1][2][3].

  • CAS Number

    [2600513-51-5]

  • Molecular Formula

    C25H22N4O5

  • Molecular Weight

    458.47

  • Smiles

    O=C1N(N=C(/C1=N/NC2=C(C(C3=CC=C(C(O)=O)O3)=CC=C2)O)C)C4=CC=C(CCCC5)C5=C4

  • Target

    Apoptosis; CDK; ERK; PI3K; STAT; Thrombopoietin Receptor

  • Isoform

    CDK4; CDK6; PI3K

  • Solubility

    10 mM in DMSO

  • Shipping Conditions

    Room temperature

Your cart
Variant Variant total Quantity Price Variant total
1 EachQM-0066293
1 EachQM-0066293
£0.00/ea
£0.00
£0.00/ea £0.00

Rafutrombopag [CAS 2600513-51-5]

Rafutrombopag is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.